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Transgenic rats carrying the mouse renin gene—Morphological char-
acterization of a low-renin hypertension model. Transgenic rats [TGR;
strain name TGR(mRen2)271 harboring the mouse Ren-2 renin gene
have been recently generated as a model for the study of primary
hypertension that offers the advantage of a clearly-defined genetic
alteration. Expression of the mouse Ren-2 gene causes severe hyper-
tension (200 to 260 mm Hg) which is responsive to converting enzyme
inhibitors. Compared to control transgene-negative littermates, plasma
renin and angiotensin II values are lowered in TGR, whereas plasma
prorenin values are strongly elevated. The adrenal gland in TGR shows
marked overexpression of mouse renin messenger RNA; in situ hybrid-
ization using a 35S-labelled mouse-renin RNA probe reveals that
enhanced renin expression is mainly localized to cells of the zona
glomerulosa and outer zona fasciculata. Immunohistochemically, renin
protein in the TGR adrenal gland is stored in larger quantities than in
controls. Adrenal transgene expression probably accounts for most of
the elevated plasma prorenin level in TGR, since bilateral adrenalec-
tomy (ADX) causes a significant decrease in prorenin level (318 79 ng
angiotensin I/mi/hr before ADX to 70 43 ng 4 days after ADX, P <
0.0005). In the kidney, renin synthesis is almost completely suppressed
in TGR. In situ hybridization demonstrates that few juxtaglomerular
afferent arterioles express renin. Immunohistochemically, the TGR
kidney shows significantly reduced renin and angiotensin II immuno-
reactivity at the afferent arteriole. Ultrastructural analysis of the
afferent arteriolar wall frequently shows the complete absence of renin
secretory granules since the granular cells are mostly converted into
smooth muscle cells. Beginning at an age of approximately four to six
months, TGR develop hypertension-related alterations and pathological
lesions in various tissues. In the kidney, the wall thickness of arterioles
and arteries is strongly increased, and glomerular lesions including
different stages of sclerosis are observed. The thoracic aorta displays a
considerable increase in tunica media thickness due to both myocyte
hypertrophy and interstitial fibrosis. Coronary arteries and arterioles of
the heart are thickened and perivascular fibrosis is observed. The data
show that TGR(mRen2)27 transgenic rats display all typical character-
istics of hypertensive pathology, making them an interesting model for
therapeutic interventions. The fact that these changes occur in animals
with a single gene difference to normotensive rats makes them a
particularly suitable model for studies on gene-related hypertensive
processes.
Disorders of the circulating renin-angiotensin system (RAS)
play a central role in the genesis and development of hyperten-
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sion. Angiotensin II, the final product of the biochemical
cascade of the RAS components, is known as a potent vaso-
constrictor and a stimulus for the secretion of aldosterone [1—4].
More recent findings have shown that in addition to the classic
sites of synthesis, multiple components of the RAS may be
found locally in a number of tissues where they may exert an
autocrine and paracrine influence on local tissue functions
[5—9]. Accumulating evidence indicates that peripheral tissues
are major sites of production of angiotensin II [2, 10]. The genes
coding for the components of the RAS have recently been
sequenced and cloned [11, 12], and local tissue gene expression
of the RAS has been demonstrated using molecular biological
techniques [13—181.
To obtain genetically defined models for the investigation of
the various tissue RAS, the regulation of the genes involved and
their respective role in hypertension, transgenic animals have
been created by several groups [12, 19]. The creation of
transgenic rats has provided wider possibilities for models in
hypertension research since rats are the more appropriate
subject for functional studies. One example of such a model is
the hypertensive transgenic rat line [TGR; strain name: TGR(m-
Ren2)27], which was constructed by introducing the mouse
Ren-2 renin gene including its flanking sequences into the rat
genome [20]. Ren-2 is a duplicated form of the renin structural
gene and is present in mouse strains expressing high levels of
submandibular gland renin. The Ren-2 gene has previously been
characterized in transgenic mice and could be expected to be
highly expressed in certain tissues [21]. The TGR develop
fulminant hypertension (200 to 260 mm Hg mean systolic blood
pressure) beginning at the fifth week of age [20]. Plasma renin
and angiotensin levels unexpectedly are lowered in TGR,
whereas angiotensinogen levels are not significantly altered.
Interestingly, levels of circulating prorenin are found to be
severalfold elevated over control values. The adrenal gland
possibly accounts for a major part of the abnormally-elevated
prorenin levels in TGR [22]. Hypertension in TGR has been
shown to be largely dependant on the conversion of angiotensin
I to angiotensin II, since low doses of a converting enzyme
inhibitor reduce the blood pressure reproducibly by 80 to 120
mm Hg [20]. The renin gene expression in these rats is lowered
in the kidney but strongly elevated in the adrenal gland. Using
an RNase protection assay designed to discriminate between
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mouse and rat renin gene transcripts, Mullins, Peters and
Ganten [201 confirmed that renin gene transcripts in the adrenal
gland were of Ren-2 origin. To a lesser extent, mouse tran-
scripts are expressed also in other tissues, such as the brain, the
thymus and parts of the intestinal tract. Thus, it is anticipated
that these rats will provide a valuable tool for the investigation
of low plasma-renin hypertension and of local tissue RAS
function.
The present study describes the local tissue renin expression
by in situ hybridization histochemistry, establishes the tissue
renin-protein localization by immunocytochemistry and pre-
sents a detailed analysis of the microanatomical characteristics
in TGR of different age at the renal and cardiovascular levels. In
addition, bilateral adrenalectomy was performed in order to
investigate the role of the adrenal gland in elevated prorenin
levels in TGR.
Methods
Animals
Transgenic rats of the hypertensive line TGR(mRen2)27 were
used in this study. These rats were produced and bred in the
Department of Pharmacology, Heidelberg, as previously de-
scribed [20]. Heterozygous hypertensive males and females
(200 to 500 g body weight, age 2 to 8 months) that had been
analyzed for the presence of transgene construct by tail biopsy
and Southern blot assay were used in this study. For the
bilateral adrenalectomy experiment, five-month-old male TGR
were used. Age-matched transgene-negative littermates were
used as controls. Systolic blood pressure was measured by tail
plethysmography under light ether anesthesia using the tail cuff
method, Values ranged between 200 and 250 mm Hg in trans-
genic males, 160 to 220 mm Hg in transgenic females and 110 to
140 mm Hg in normotensive controls. No pharmacological
intervention was performed to lower the blood pressure of the
hypertensive animals.
Tissue preparation for morphology
For conventional morphological investigation using light and
electron microscopy, animals were anesthestized by an i.p.
injection of Nembutal (40 mg/kg body wt) and perfusion-fixed
by cannulation of the abdominal aorta as described [231. Ani-
mals were perfused at a pressure of 240 mm Hg for 2 minutes
with a mixture containing 1.5% paraformaldehyde and 1.5%
glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4. Total
osmolality of the fixative was 800 mOsmlkg H20. After perfu-
sion, kidneys, adrenals, heart and thoracic aorta were removed
and postfixed for an additional 24 hours in the same fixative.
Subsequently, small tissue cubes were prepared and rinsed in
cacodylate buffer adapted to the osmolality of the fixative with
sucrose. The tissue was then postfixed in a 1% aqueous osmium
tetroxide solution and plastic-embedded after dehydration in a
series of graded alcohols. Epon 812 was used as embedding
medium. For light microscopy, semithin sections (1 m) were
cut and stained in Richardson's solution. Ultrathin gray sec-
tions were contrasted in uranyl acetate and lead citrate and
viewed in a Philips 301 electron microscope.
Immunohistochemistry
Immunohistochemical studies were performed for the local-
ization of renin and angiotensin II in the kidney and adrenal
gland. For this purpose, hypertensive transgenic animals as
well as normotensive controls of both sexes were anesthetized
and perfusion-fixed as described above, using 2% paraformal-
dehyde in phosphate-buffered saline (PBS), pH 7.4, at room
temperature. Total osmolality of the fixative was 800 mOsmol.
After perfusion, the kidneys and adrenals were removed and
postfixed in the same solution for two hours. Tissue was rinsed
in PBS adated to the osmolality of the fixative by addition of
sucrose and then routinely embedded in Paraplast; 5 im
sections were mounted on acid-cleaned chrome-alum coated
glass slides. Immunohistochemical staining for renin was per-
formed using a polyclonal rabbit antibody against purified
mouse submandibular gland renin ([24], from Dr. T. Inagami,
Vanderbilt University, Nashville, Tennessee, USA). This anti-
body was used at dilutions of 1:500, 1:5000 and 1:10000,
depending on the tissue. Detection of the bound antibody was
performed using a peroxidase-antiperoxidase detection system
(PAP; Dakopatts, Denmark). Sections were subsequently ex-
posed to 0.1% diaminobenzidine and 0.02% H202 as a source of
peroxidase substrate. For comparison, a rabbit polyclonal
antibody against purified rat kidney renin was used at dilutions
between 1:5000 and 1:50000 (antibody was from Dr. E. Hack-
enthal, Dept. of Pharmacology, Heidelberg, Germany). For
detection of angiotensin II, a rabbit polyclonal antibody against
angiotensin II was used at dilutions between 1:5000 and
1:10000). Control experiments were made by omitting the first
antibody step (iticubation with 1% normal nonimmune rabbit
serum instead). Sections were not counterstained, and were
viewed in a Reichert Polyvar microscope using interference
contrast optics.
In situ hybridization
For in situ hybridization experiments, hypertensive rats as
well as norn-iotensive controls of both sexes weighing between
200 and 400 g were anesthetized with diethylether. Mter
opening of the peritoneal cavity, kidneys and adrenal glands
were quickly removed and tissue was treated as described 125].
To generate the hybridization probes, a SacI/PstI fragment of
the mouse Ren-2d cDNA was subcloned into a pSP65 transcrip-
tion vector to generate cRNA and into the pSP64 vector to
generate mRNA. The plasmids were linearized using either
AccI for the pSP65 plasmid to generate an appropriate template
for in vitro transcription of renin antisense RNA (template
pSLM-mRE25I), or KpnI for the pSP64 plasmid to obtain a
template for the renin sense RNA (template pMLS-mRE248)
using established techniques. The probe size was approxi-
mately 330 base pairs. The plasmids were from Dr. K. Gross
(Buffalo, New York, USA) [21].
The in vitro transcription wa carried out using SP6 polymer-
ase (ProMega; 1 U/id to generate cRNA and mRNA, respec-
tively, in the two plasmids) at 370 for 90 minutes. For transcrip-
tion, one pg of linearized plasmid DNA, 48 pmol [35S]-a-labeled
UTP (Dupont NEN; sp. act. 1350 Cilmmol), 40 nmol ATP, CTP
and GTP, respectively, and 240 pmol UTP were incubated for
one hour at 40°C in a mixture containing 40 m Tris-HC1 (pH
7.5), 6 mt MgCl2, 2 m'vi spermidine, 10 mri NaCl, 100 pMDTT
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and 1 U/ui RNase inhibitor (Promega). The DNA template was
then digested by adding 20 ng//Ll RNase-free DNase I for 15
minutes at 37°C in the presence of I U/t.d RNase inhibitor. The
transcripts were then purified in phenol and chloroform-isoamyl-
alcohol (each at 1:1 vol/vol) and separated from non-incorpo-
rated nucleotides by ethanol precipitation, checked by denatur-
ing formaldehyde gel electrophoresis, and used directly for the
in situ hybridization experiments. The specific activity of the
probes was in the order of 5 x 108 dpm/p.g RNA.
For in situ hybridization, alternate sections were used for
sense and antisense probe hybridization. Sections were washed
two times for 10 minutes in sterile water followed by a depro-
teination in 0.1 M HC1 for 10 minutes. After two short washing
steps (3 mm) in PBS the slides were acetylated for 20 minutes in
0.1 M triethanolamine/0.25% acetic anhydride (pH 8.0). Next
the slides were washed two times (5 mm) in PBS, dehydrated in
graded ethanol and air dried. Subsequently, 150 d of a prehy-
bridization mixture containing 50% deionized formamide, 50
mM Tris-HC1 (pH 7.6), 25 mrt EDTA, 20 mri NaC1, 0.25 mglml
yeast tRNA, 2.5x Denhardt's solution (lOOX = 0.05% ficoH,
0.05% polyvinylpyrolidone, 0.05% bovine serum albumin) were
applied to the sections; they were incubated at 37°C for two to
four hours in a humidified chamber. Next the slides were
drained and 10 zl hybridization buffer (50% deionized formam-
ide, 20 m Tris-HCI, pH 7.6, 1 mii EDTA, pH 8.0,0.3 M NaC1,
0.1 M DTT, 0.5 mg/ml yeast tRNA, 0.1 mg/mi poly-A, lx
Denhardt's solution, 10% dextransulphate) containing either 5
or 20 pg of labeled cRNA or mRNA were were applied per
section. Activity of the final probe was approximately 3000 and
10000 dpm/pi, respectively. The sections were covered with
small pieces of Paraflim and incubated in a humidified chamber
at 37°C for 16 to 18 hours. After hybridization, the Parafilm was
removed in 2x standard saline citrate (SSC) at 48°C. Next, the
slides were washed in lx SSC/50% formamide at 48°C for six
hours. The washing solution was changed every 90 minutes.
Final high stringency washes were carried out with either 1 x or
0.5x SSC, each at room temperature two times for 10 minutes.
Next, the slides were dehydrated in a series of graded ethanol
and air dried. The sections were dipped in a 50% NTB-2
emulsion (Eastman Kodak, Rochester, New York, USA) in
water at 45°C, exposed at 4°C in bakelite boxes containing
desiccant, developed with D19 developer (Kodak) and fixed
with Unifix (Kodak). The time of exposure of the slides was
either 5, 10 or 30 days.
Bilateral adrenalectomy (ADX)
For the ADX experiment, two groups of rats were estab-
lished: one group of normotensive nontransgenic littermates (N
= 5), and one group of hypertensive transgenic rats (N = 5). In
both groups, ADX was carried out under ether anesthesia by
opening of the abdominal cavity. After operation, all animals
were supplemented with 0.9% saline as the only drinking
source. In all animals, blood pressure was measured and blood
was taken three days before surgery and four days after
surgery. Blood specimens were collected in EDTA for deter-
mination of active renin and prorenin as described [26]. Values
are given as nanograms of angiotensin I (ng Ang I) per milliliter
plasma per hour. Statistically, changes were analyzed using
ANOVA followed by paired t-test. Differences of a level of P <
0.05 were considered significant. The values are given as means
standard deviation.
Results
Renin-angiotensin system in the adrenal gland
For in situ hybridization using a mouse renin mRNA probe,
adrenal glands of male and female transgenic and control rats of
an age ranging from two to six months were examined. The
ream probe used in the assay cross-hybridized with both mouse
and rat renin mRNA and was therefore applied to both the
tissues of TGR and controls.
Renin gene transcripts were 10 to 100 times more frequent in
the TGR adrenal cortex, than in controls (Fig. 1 a-c). Labelling
was enhanced in both sexes. The hybridization signals were
restricted to the adrenal cortex in both transgenic and control
animals. No specific autoradiographic grains were detected in
the medulla or in the organ capsule (Fig. 1 a-e). In TGR, the
strongest density of renin transcripts was found at inner layers
of the zona glomerulosa and in the outermost region of the zona
fasciculata at the border to the zona glomerulosa. In this region,
scattered single cells or groups of two to four cells revealed a
particularly strong hybridization signal. Particle density in these
cells outnumbered the surrounding basic grain density by
approximately fivefold (Fig. la). In some cells, the hybridiza-
tion signal over the nuclei was enhanced. Hybridization signal
over the inner zona fasciculata was less strong and autoradio-
graphic grains were more evenly distributed. In the zona
reticularis, patches of 30 to 100 cells bordering the adrenal
medulla showed an increased signal about twice as strong as in
the inner zona fasciculata (Fig. id). Hybridization signal in the
normotensive control adrenal glands was generally low in the
cortex with no recognizable zonal differences (Fig. 1 c,e).
Background labelling was minimal or nonexistent under the
high-stringency washing conditions employed.
For detection of renin protein, deparaffinized sections of the
adrenal glands of TGR and control rats were incubated with a
polyclonal anti-mouse renin antibody which, however, was not
totally species-specific but cross reacted to some degree with
the rat antigen. The TGR adrenal glands revealed stronger
antibody labelling than the controls; labelling was localized at
the outer zona fasciculata in close analogy to the in situ
hybridization signal (Fig. 2a). The inner zona fasciculata in
TGR was almost devoid of renin whereas in the zona reticularis,
similar to renin mRNA distribution, patches of reactive cells
could be observed. In control adrenal glands, antibody staining
in the same concentration range applied for the TGR adrenal
glands was so weak that the label could barely be visualized
(Fig. 2c). In more detail, cellular immunoreactivity disclosed
small labelled granules grouped around the nucleus (Fig. 2b).
No cellular immunoreactivity could be detected in the adrenal
gland of TGR or controls using an antibody against angiotensin
II. Comparison of the light and electron microscopical structure
of perfusion-fixed adrenal glands from both groups revealed a
striking morphological heterogeneity between individual ani-
mals, but it was not possible to assign a specific pattern to one
or the other animal group.
Influence of the adrenal renin expression on plasma prorenin
level
To test whether the overexpression of adrenal renin mRNA is
related to the elevated plasma prorenin levels in TGR, a
bilateral adrenalectomy (ADX) was performed in two groups of
rats, one composed of TGR, the other of normotensive controls
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Fig. 1. In situ hybridization analysis of renin mRNA expression in the adrenal gland using a mouse-renin riboprobe. a. In TGR, the adrenal cortex
reveals strongly enhanced expression in the zona glomerulosa and the outer zona fasciculata (arrowheads mark the approximate border between
these zones). Note that single cells and smaller groups of cells show a particularly enhanced expression (antisense probe). b. In the same tissue,
a control renin probe (sense probe) does not show significant labelling. c. The outer cortex of a normotensive control adrenal gland reveals a low
level of renin mRNA expression (antisense probe). a-c. Hematoxylin-eosin, x 600. d. The zona reticularis (ZR) in a TGR adrenal gland reveals
areas of enhanced renin expression at the border to the adrenal medulla (M). e. Same localization as in d; the zona reticularis of a normotensive
control shows expression no higher than background level. d,e: The cortico-medullary border is indicated by dashed lines. Antisense probe,
hematoxylin-eosin, x 600.
(Fig. 3). Plasma prorenin was determined before and four days Ang I/mi/hr vs. 318 79 ng; P <0.005; Fig. 3). Blood pressure
after ADX. Prior to ADX, prorenin was approximately twelve- was 128 5 mm Hg in controls versus 210 13 mm Hg in TGR
fold higher in TGR than in normotensive controls (27 29 ng (P < 0.005). After ADX, prorenin levels in TGR were lowered
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Fig. 2. Immunohistochemical localization of renin in the adrenal cortex, a. The innermost layers of the zona glomerulosa and the outer layers of
the zona fasciculata reveal enhanced immunostaining in a TGR adrenal gland. The arrowhead indicates the approximate border between the two
cortical zones, X 610. b. Higher resolution of a TGR adrenal cortex showing granular renin-positive structures (arrows), x 1000. c. Control adrenal
gland. Renin-immunostaining is deficient in the cortex using the same antibody dilutions as in a, x 610. a-c: Interference contrast microscopy.
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Fig. 3. Effect of bilateral adrenalectomy on plasma prorenin levels in
normotensive controls (N = 5; bars 1,2) and TGR (N = 5; bars 3,4).
Plasma prorenin values before ADX (solid bars) and 4 days after ADX
(hatched bars). Values are given standard deviation. Statistical
significance of the difference between bars 3 and 4: P < 0.005.
to 70 43 ng Ang I/mi/hr (P < 0.005) whereas in controls,
prorenin remained unchanged (26 55 ng Ang I/mllhr). Blood
pressure in TGR was significantly lowered after ADX (163 23
mm Hg, P < 0.005), but was unchanged in controls (128 6mm
Hg). Plasma active renin in TGR was lower than in controls (14
9 ng Ang I/mi/hr vs. 45 41; P < 0.05). After ADX, active
renjn levels were raised in both strains; in TGR however, values
were not significantly increased (78 75 ng Ang I/ml/hr),
whereas in controls, the increase was significant (177 87 ng
Ang I/ml/hr; P < 0.05).
Renin-angiotensin system in the kidney
For renin mRNA localization by in situ hybridization, kid-
neys from male and female TGR and controls aged between
three and eight months were investigated using the same probe
as for the adrenal glands. Renin mRNA expression at the
juxtaglomerular apparatus in TGR was generally suppressed to
a strong degree (Fig. 4a). As an exception, just a few glomeruli
exhibited a clearly visible grain clustering at the afferent arte-
riole that was comparable to the autoradiographic signal in
controls. It appeared, however, that the suppression of renin
expression was depending on the degree of hypertension.
Female TGR or older male TGR which occasionally revealed
blood pressure values near normotension exhibited an almost
normal level of renin gene expression, whereas in strongly
hypertensive specimens numerous glomeruli did not reveal any
expression signal at the vascular pole. Renin expression in the
normotensive control kidneys was limited to the arterial tree at
the regular juxtaglomerular site (Fig. 4b). Tubular epithelia,
interstitial cells and capillaries never showed a hybridization
signal.
Immunocytochemical labelling of the kidneys using the anti-
mouse renin antibody revealed a reaction pattern analogous to
that obtained from in situ hybridization. In the hypertensive
rats, numerous afferent arterioles did not reveal any immuno-
staining at all at the juxtaglomerular apparatus (Fig. 4c), and in
others, only few reactive cells per longitudinally-sectioned
afferent arteriole were visible. Controls revealed strong anti-
body labelling over the juxtaglomerular granular cells (Fig. 4d).
For comparison, the sections were stained with an anti-rat renin
antibody which specifically recognized rat but not mouse renin.
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Fig. 4. Renin in situ hybridization (a,b), renin immunohistochemistry (c,d) and angiotensin II immunohistochemistry (e,f) ofTGR (left side of the
panel) and control kidneys (right side of the panel). a. No renin in situ hybridization signal is visible at three glomerular vascular poles (arrows)
indicating suppressed renin expression in the TGR kidney; for better visibility, glomeruli as well as afferent arterioles are outlined by dashed lines.
b. In the control kidney, normal renin mRNA-expression is localized to the vascular poles of three glomeruli (arrows). a,b: Antisense mouse renin
probe, hematoxylin-eosin, x 100. c. No renin-immunoreactivity is found in the wall of an afferent arteriole (A) of a TGR glomerulus; efferent
arteriole (E), niacula densa (arrow). d. In the control kidney, normal renin-immunostaining is seen in the wall of the afferent arteriole. c,d:
Anti-mouse renin antibody, interference contrast microscopy, x 450. e. No angiotensin IL-immunoreactivity is found in the wall of an afferent
arteriole (arrow) of a TGR kidney. f. In the control kidney, angiotensin Il-immunoreactivity is concentrated in the wall of two afferent arterioles
at the glomerular vascular pole. e,f: Anti-angiotensin II antibody; interference contrast microscopy, X 115.
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Staining with this antibody was much the same as with the
mouse antibody (results not shown). Immunostaining with an
antibody directed against angiotensin II showed the same
pattern of reactive cells in the wall of the afferent arteriole, as
observed with the renin antibody (Fig. 4 e,f).
The light microscopical findings were corroborated by ultra-
structural studies of aldehyde-perfused transgenic kidneys; it
was found that in the classic juxtaglomerular position of the
afferent arteriole, the number of granular cells was strongly
reduced and a total absence of these cells was encountered in
some of the arterioles (Fig. 5 a,b). Only few afferent arterioles
were encountered containing small numbers of renin-type gran-
ules. Control kidneys of the same preparation exhibited the
normal aspect of granular cells arranged in several layers in the
tunica media of the afferent arteriole near the glomerulus; the
cells contained abundant renin-type granules (Fig. 5 c,d).
Pathological alterations of the kidney
A number of striking morphological alterations was found in
the kidneys of the transgenic animals (Figs. 6 a-g, 7 a-c). The
changes were by far more evident in males than in females, and
were seen to increase considerably between the fourth and sixth
month of age. A general pattern present in all hypertensive rats
investigated irrespective of sex and age, was a prominent
increase of the arterial wall-thickness-to-lumen diameter ratio
of the large kidney arteries, that is, the arcuate and interlobular
arteries and, to a lesser extent also the more proximal portions
of the glomerular afferent arterioles (Fig. 7 a-c). The increase in
media thickness was regularly paralleled by an enlarged inter-
stitial space surrounding the individual smooth muscle cells;
this space was filled with basement membrane-like material,
collagen fibers and debris of vesicular structures (Fig. 7c).
However, signs of myocyte degeneration or fibrinoid necrosis
were absent.
Lesions of the nephron were inconspicous both in male and
female TGR at an age of four months. At six and eight months
of age, however, male kidneys had regularly developed glomer-
ular lesions as well as focal tubular atrophy together with
interstitial accumulations of inflammatory cells. In six-month-
old kidneys, roughly 10% of the glomeruli were damaged to
varying extent. In eight-month-old kidneys the proportion of
damaged nephrons was considerably increased and end-stage
sclerotic glomeruli were frequent (Fig. 6). Thickening of Bow-
man's capsule was observed in many glomeruli. Most strik-
ingly, glomeruli with a strongly widened Bowman's capsule
occurred in midcortical and juxtamedullary position; these
glomeruli were dominated by a dilated urinary space that
dwarfed the glomerular tuft (Fig. 6b). The tuft morphology in
these glomeruli, however, appeared to be intact. Other glomer-
ular damages included mesangial expansion (Fig. 6a) as well as
subendothelial hyalin deposits occluding the capillary lumen
Fig. 5. Ultrastructural morphology of the renal afferent arteriole at the
vascular pole of the glomerulus. a. In TGR, the muscular layer of the
juxtaglomerular afferent arteriole frequently does not contain granular
cells, x 1200. b. The cells of the tunica media present the typical aspect
of vascular smooth muscle cells filled with myofilaments, X 5000. c. In
the normotensive control, the renal afferent arteriole reveals granular
cells in the tunica media; the granule-containing portion of the arteriole
is outlined by arrows, x 1200. d. Detail of the control afferent arteriole
showing large mature renin granules which occupy almost the entire
cytoplasm of the granular cells, x 5000. a-d: Ultrathin sections.
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Fig. 6. Hypertension-induced lesions of the renal corpuscle, a. A glomerulus of a TGR kidney revealing attenuation of the visceral epithelium with
pseudocyst-formations (arrowheads) and focal expansion of mesangial elements (arrows), x 330. b. Widely dilated urinary space of a TGR
glomerulus with a fairly normal glomerular tuft structure, x 240. c. Hyalin deposition in a totally collapsed TGR glomerulus, x 310. a-c: Semithin
sections, toluidine blue. d. Ultrastructure of pseudocyst formation in TGR glomerular visceral epithelium. Distended podocytes may bridge two
or more capillary loops. Note the increased number of lysosomes, x 3500. e. Sclerotic end stage of a collapsed TGR glomerular capillary loop;
note the folded glomerular basement membrane, x 7200. f. Retraction of podocyte foot processes in a TGR glomerular visceral epithelium,
x 11800. g. Normal aspect of glomerular podocyte foot processes in a control glomerulus, x 18700. d-g: Ultrathin sections.
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Fig. 7. Hypertension-induced morphological alterations of the renal arcuate artery (a-c) and of intramyocardia! coronary arterioles of the heart
(d,e). Compared with a control (a), the tunica media of the renal arcuate artery in TGR (b) is significantly thickened and there is expansion of the
interstitial matrix. Note the difference in thickness of the internal elastic lamina (arrows). There is no obvious size difference of media myocytes
between the hypertensive and the normotensive. a,b: Ultrathin sections x 2280. c. Higher magnification of a TGR renal arcuate artery revealing
increase in basement membrane-like material and collagen fibres between myocytes of the tunica media. Ultrathin section, x 10900. Coronary
arterioles of a similar external diameter in a control (d) and a TGR heart (e); note the increase in tunica media thickness as well as the obvious
myocyte hypertrophy in the TGR arteriole. The TGR arteriole reveals perivascular fibrosis. d,e: Semithin sections, toluidine blue, x 256.
(Fig. 6c). These lesions were segmental in some glomeruli and
generalized in others. Microaneurysms were infrequent. Alter-
ations of glomerular epithelial cells comprised the formation of
large cytoplasmic vacuoles, a strong increase in large secondary
lysosomes, as well as the development of pseudocysts of
extended podocytes that appeared to bridge two or more
capillary loops (Fig. 6 a,d). Retraction of podocyte foot pro-
cesses occurred in many glomeruli with a concomitant loss of
tertiary structure and a narrowing of the filtration slit (Fig. 60.
Degradation of the capillary wall or separation of the epithelium
from the underlying basement membrane were rarely seen.
End-stage sclerotic glomeruli were characterized by a total
collapse of capillary lumen and a dense accumulation of heavily
folded and thickened basement membrane surrounded by de-
generated and fused podocytes (Fig. 6e). Some areas of dam-
aged nephrons revealed shrunken glomeruli as well as atrophic
dilated tubules with luminal casts and a thickened tubular
basement membrane.
Pathological alterations of the heart
An increase in heart size was regularly observed in all
transgenic rats when compared to age-matched normotensive
littermates. Apart from hypertrophy, pathological changes of
the heart were rather inconspicous in the transgenic animals
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with respect to myocardial and coronary morphology. Myocar-
dial arterioles and coronary arteries clearly revealed an increase
in media thickness in the transgenic males, and the media
myocytes were hypertrophied revealing a strong increase of the
cytoplasmic portion occupied by myofibrillae (Fig. 7 d,e).
Focally, perivascular fibrosis occurred in the form of enlarged
areas of extracellular connective tissue matrix encircling myo-
cardial arterioles. In these areas, the surrounding myocardial
cells were separated from each other by fibrous interstitial
matrix. Pathologic changes in female TGR hearts were by far
less evident than in males, as the females presented an overall
intact tissue aspect. A systematic statistical analysis of the
hypertensive changes has not been achieved as yet due to the
small number of animals available for this study.
Pathological alterations of the aorta
Wall thickness of the thoracic aorta was strongly increased in
transgenic animals of both sexes when compared to their
normotensive littermates. Thickness of the tunica media in
males was almost doubled at an age of six months (Fig. 8 a,b).
Strikingly, in TGR a change in the overall structure of the media
layers was observed: in controls, five to seven layers of
circularly-oriented elastic laminae separating the smooth mus-
cle layers were arranged regularly. In the hypertensive animals,
however, this regular arrangement was disturbed by the forma-
tion of elastic fibrous bridges that formed an interweaving
network of additional layers between the myocytes with no
recognizable specific orientation. Ultrastructurally, the extra-
cellular connective tissue matrix was enlarged proportionally to
the hypertrophy of the smooth muscle cells. Strongly enlarged
collagenous fiber bundles were intermingled with large elastic
fibers (Fig. 8 c,d). There were no obvious signs of damage at the
level of the endothelium and the internal elastic layer.
Discussion
This study presents morphological and functional data of a
new hypertensive rat strain transgenic for the mouse Ren-2
gene. The localization and expression of RAS components were
documented. Renal and cardiovascular morphology were inves-
tigated.
The most striking result obtained from the in situ hybridiza-
tion experiments was the strongly-enhanced renin gene expres-
sion in the TGR adrenal gland. Even though the probe used in
the in situ hybridization assay did not allow a specific distinc-
tion between mouse and rat renin transcripts, data presented by
Mullins and coworkers [201 allow the indirect conclusion that
adrenal renin expression levels exceeding control levels were
due to expression of the mouse transgene.
Renin mRNA expression was enhanced over the entire
Fig. 8. Hypertension-induced morphological alterations of the tho-
racic aorta (at the transition of the aortic arch to the straight part). a,b.
Aorta of a 6-month-old male control (a) and of an age-matched male
TGR (b); wall thickening in the TGR aorta is evident, and the muscle
layers are interwoven with the elastic laminae. a,b: Semithin sections,
toluidine blue, x 380. c,d. Normal control (c) and age-matched hyper-
tensive aorta (d), age: 6 months. Note the regular arrangement of
smooth muscle cells and elastic laminac of the tunica media in the
control; in the hypertensive aorta, interstitial collagenous and elastic
deposits are increased. c,d: Ultrathin sections, x 2660.
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adrenal cortex and was specifically concentrated in the zona
glomerulosa and outer fasciculata. Renin expression in control
adrenals was weak and more evenly distributed over the cortex.
A previous in situ hybridization study [13], however, reports
that in the normal rat adrenal gland a narrow zone of the outer
cortex revealed an enhanced expression of renin mRNA. These
authors conclude that in the rat, the zona glomerulosa is the
main site of adrenal renin synthesis.
Adrenal expression of the mouse Ren-2 gene in transgenic
animals has already been studied previously by Mullins and
coworkers [21]. These authors found that a one-renin-gene
mouse strain (Renl-c/Renl-c) made transgenic for the mouse
Ren-2 gene revealed a strongly enhanced constitutive expres-
sion of the transgene in the female adrenal gland. In the male
adrenal gland, however, transgene expression level was com-
paratively low and corresponded to the level of the wild type
expression of Ren-2 in the DBA/2J strain from which the
transgene was derived. These results differ from TGR adrenal
renin expression which was strongly enhanced both in males
and females; the discrepancy may be due to species-specific
genomic differences.
Immunoreactive renin in the TGR adrenal gland was local-
ized to the same adrenal cortical zones that revealed high gene
expression levels. Compared to the high increase in mRNA
expression in the TGR adrenal cortex, however, immunoreac-
tive renin was only moderately enhanced over control levels.
This finding suggests that renin or its inactive precursors are
mostly secreted rather than stored in the adrenal gland. Both in
TGR and in control adrenal cortex, the majority of immunore-
active cells were located in the outer cortical zone, that is, in
the zona glomerulosa and the outer zona fasciculata. This
agrees with other reports on rat adrenal renin immunoreactivity
[13, 27, 28], whereas in the mouse adrenal gland, Naruse and
coworkers [29] found immunoreactive renin to be preferentially
localized in the inner adrenal cortex.
The mechanism of action of the increased adrenal renin
mRNA level on the genesis and maintenance of hypertension in
TGR is not clear. It is now generally acknowledged that, as for
many other tissues, the adrenal gland contains the complete
endogenous renin-angiotensin system and is involved in the
regulation of blood pressure [30—32]. The adrenal RAS may act
by a direct effect of angiotensin II or by controlling aldosterone
biosynthesis [3, 6, 16, 27, 33] and by the angiotensin IT-induced
release of medullary catecholamines [34, 35]. However, plasma
catecholamine levels (unpublished results) and plasma angio-
tensin II levels [20] were not significantly altered in TGR;
urinary aldosterone levels in TGR were roughly twice above
normal [20] but were probably not sufficiently elevated to fully
account for the strongly-elevated blood pressure in these ani-
mals.
On the other hand, the most conspicuous value of the plasma
RAS parameters in TGR is the high prorenin level which
exceeds control values by approximately twelvefold. Prorenin
is now recognized to be identical to plasma inactive renin, and
it has recently been found that prorenin can be converted to
active renin in the liver, kidney and adrenal gland [36]. To
establish a relation between the elevated adrenal renin mRNA-
expression and plasma prorenin levels, a bilateral adrenalec-
tomy (ADX) was performed in hypertensive transgenic rats and
in normotensive littermates. ADX significantly lowered plasma
prorenin to about 22% of the initial value. Even though after
ADX prorenin levels in TGR are still a little, but not signifi-
cantly higher than in controls, this study provides evidence that
the adrenal gland is likely to be the major source of prorenin. It
may thus be concluded that the adrenal renin mRNA overex-
pression accounts for a major share of the elevated prorenin
level in TGR. Whether prorenin secretion may be varied by
changes in volume homeostasis, is unclear at present; gener-
ally, prorenin is known to be secreted constitutively [37].
Plasma active renin levels four days after ADX were increased
in the control group but were not significantly raised in TGR;
the reason for this discrepancy may well be based on the fact
that a normal amount of renin producing cells present in the
control kidneys may strongly react to a secretion stimulus,
whereas in TGR, metaplastic transformation of smooth muscle
cells into granular renin secreting cells probably has to occur
before renal renin production reaches levels equivalent to the
control group. This process may require a time span longer than
four days.
Blood pressure in TGR was lowered after ADX; however,
this cannot provide evidence for the adrenal prorenin produc-
tion as the direct cause of hypertension, since the lack of
mineralocorticoids induced by the bilateral ADX may equally
well account for a lowered blood pressure. Thus, the role of
prorenin in TGR on the genesis of hypertension will have to be
further elucidated.
The present study clearly underlines that hypertension in
TGR is not due to renin overexpression in the kidney, since
intrarenal renin protein and mRNA levels were suppressed. The
results are in agreement with previous data which established a
low renal renin activity in TGR [20]. Renin transcripts were
rarely detectable by in situ hybridization at the vascular poles of
glomeruli in TGR, whereas the controls revealed normal levels
of renin expression at the juxtaglomerular afferent arteriole as
previously described elsewhere [13, 38]. Immunohistochemi-
cally, the majority of the juxtaglomerular afferent arterioles was
devoid of renin as well as angiotensin II immunoreactivity.
Most of the afferent arterioles investigated did not show the
typical renin producing granular cells but rather, at the site
where granular cells are normally located, smooth muscle cells
were encountered. Since it may readily suggest that granular
cells had been present before the onset of hypertension, this
finding indicates that an extensive transformation of renin
containing cells into vascular smooth muscle cells must have
occurred. The suppression of kidney renin synthesis is probably
a secondary effect of the elevated blood pressure in TGR as has
been shown in other hypertensive models [391. On the other
hand, the relation between renal renin status and hypertension
in TGR differs from that in spontaneously hypertensive rats
(SHR) which reveal renal renin levels similar to normotensive
controls [40], even though systolic blood pressure elevation is
similar in both SHR and TGR.
Structural lesions of the nephron in TGR were moderate in
both sexes at an age of four months, except for an overall
increase in wall thickness of the larger arterioles and arteries.
Damages were seen to increase considerably in male TGR six to
eight months of age. Damages in the (less hypertensive) females
were much weaker and sometimes not observable. Systemic
hypertension has long been recognized as a significant com-
pound of progressive renal disease [41]. The observed patterns
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of glomerular damage in TGR, that is, mesangial expansion,
hyalin deposits, lesions in podocyte structure and finally gb-
merulosclerosis, are typical for experimental models develop-
ing glomerular capillary hypertension [42]. Since glomerular
lesions in TGR were occurring at a relatively early age, it
appears that the systemic hypertension, at least to some extent,
is transmitted to the gbomerulus via the gbomerular afferent
arteriole.
The increases of thickness of the tunica media observed in
the muscular type arteries as well as in the aorta of the TGR are
in agreement with those observed in other hypertensive rat
strains [43—47]. In SHR, mass of the aortic media is known to
increase proportionally with variations in systolic blood pres-
sure [46]. Hadjiisky, Peyri and Grosgogeat [44] reported a 26%
increase in aortic wall thickness in seven-month-old SHR when
compared to normotensive controls, and described similar
modifications as found in TGR with respect to thickness of the
interlamellary spaces and increase in collagen around myocytes
and along the elastic laminae. The extent of thickening of the
renal and coronary arteries and arterioles in TGR, accompanied
by varying degrees of interstitial fibrosis, was comparable to
SHR vascular morphology, exhibiting thicker walls than age-
matched normotensive rats Wistar-Kyoto rats [45, 47]. Gener-
ally, vascular hypertrophy in adult TGR is probably based on
myocyte hypertrophy and only to a small extent to hyperplasia,
since in hypertension, hyperplasia is supposed to be completed
at an early stage [46].
The cause leading to the vascular changes in TGR is un-
known. The media hypertrophy may either be the result of an
adaptive process in response to the elevated blood pressure
[48], or blood vessel thickness may already be increased prior
to hypertension development, as was observed in the renal
vasculature of SHR [49]. The overall vascular hypertrophy in
TGR may as well be the consequence of a local expression of
the transgene or activation of prorenin and, consequently,
locally acting angiotensin II, which is known to provoke myo-
cyte hypertrophy [50] and to increase peripheral vascular
resistance [51]. In view of the great complexity of mechanisms
possibly acting on the increase of vascular resistance, however,
these speculations must await further experimental data on
TGR blood pressure regulation.
In conclusion, the construction of transgenic rats provides a
new opportunity for investigating the pathogenesis of hyperten-
sive damages. Even though the cause of hypertension in the
mouse Ren-2 transgenic rats is not yet fully established, this
new animal strain may serve as a genetically well defined, low
plasma-renin hypertension model that will permit new insights
in the mechanisms of the development of glomeruloscierosis
and cardiovascular damage.
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